Dr. David Huntsman Director, Ovarian Cancer Research Program Dr. Huntsman is Professor, Pathology and Laboratory Medicine, UBC; Medical Director, Centre for Translational and Applied Genomics, BC Cancer Agency; Co-Founder and Acting-Director, OvCaRe; Co-Director, Genetic Pathology Evaluation Centre, VGH; Associate Director, Hereditary Cancer Program, BC Cancer Agency; and member of Vancouver Coastal Health Research Institute. Dr. Huntsman was part of the team that discovered EMSY, a new gene related to ovarian cancer. His current focus of study is the genetic predisposition to ovarian cancer. His research focuses on understanding the molecular differences between the different ovarian cancer subtypes, which will hopefully lead to more specific treatments. Recently, he headed the research group that discovered a new mutation in a gene called FOXL2, which appears to be responsible for the development of granulosa cell tumours of the ovary. Dr. Huntsman has active research programs in the development of predictive and prognostic tissue-based cancer biomarkers of a wide variety of tumour types as well as hereditary gastric cancer. As collaboration is critical in his field, Dr. Huntsman happily leads and engages in a wide number of multidisciplinary research groups. You can read Dr. Huntsman's blog posts here.